JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD.

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

002566

CNE1000011C3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
6.86 ^CNY	-3.65%		-3.79%	-23.01%

Apr. 25	Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021

May 12, 2022 at 03:37 pm EDT

Jilin Jian Yisheng Pharmaceutical Co., Ltd. announced that at its Annual General Meeting of 2021 held on 11 May 2022, approved cash dividend/10 shares (tax included) of CNY 0.30000000 for the year 2021.

Latest news about Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
Jian Yisheng Pharma Sets Up 3 Million Yuan Subsidiary	Mar. 07	MT
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
China's Procurement Office Selects Jilin Jian Yisheng Pharmaceutical Drug for Centralized Procurement	23-07-06	MT
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022, Payable on 7 July 2023	23-05-15	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2022	23-04-19	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 07, 2022	22-06-30	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Announces Board Appointments	22-05-12	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-12	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-20	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-19	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-22	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-17	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020, Payable on May 18, 2021	21-05-10	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year 2020	21-04-19	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-16	CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-23	CI

Chart Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Duration

Period

Chart Jilin Jian Yisheng Pharmaceutical Co., Ltd.

More charts

Company Profile

JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, production and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular disease. The Companyâs main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The Company's products are applied in the treatment for heart cerebrovascular diseases and detoxification. The company also provides health care products and cosmetics. The Company distributes its products within China market.

Sector

Pharmaceuticals

Calendar

2024-05-10 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD.	-23.01%	313M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B